Chatham Lodging Trust (CLDT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Achieved 4% RevPAR growth in Q4 2024, outperforming industry and maintaining leading EBITDA margins among select service hotel REITs.
Sold or under contract to sell six older, low-RevPAR hotels for $101 million, reducing leverage to 23% from 25% last year and nearly 35% in 2019.
Returned $22 million in dividends to shareholders and participated in GRESB, earning four out of five stars and a Green Star, ranking 2nd in peer group.
Business travel demand drove strong non-seasonal month RevPAR growth, with leisure travel softening in summer months.
Net loss narrowed to $1.9M from $9.3M in Q4 2023; net loss per diluted share improved to $(0.08) from $(0.23).
Financial highlights
Q4 2024 revenue was $75.1M, up from $72.3M in Q4 2023; full-year revenue reached $317.2M.
Q4 hotel EBITDA was $24.3M; Adjusted EBITDA $21.4M; Adjusted FFO $0.20 per share.
GOP margin for Q4 was 41%, hotel EBITDA margin 33%, both up year-over-year.
Net debt reduced by $29M in 2024, following a $26M reduction in 2023.
Dividends per common share: $0.07 for Q4, $0.28 for 2024.
Outlook and guidance
2025 guidance: RevPAR growth of 1%-3.5%, Adjusted EBITDA $92-$97M, Adjusted FFO per share $1.01-$1.11.
Q1 2025 guidance: RevPAR growth 3%-4%, Adjusted EBITDA $16.7-$18.3M, Adjusted FFO per share $0.12-$0.15.
Hotel EBITDA margin projected at 34.8%-35.8% for 2025.
Guidance assumes proceeds from asset sales are used to repay debt; no acquisitions included but plans to reinvest in accretive assets.
Latest events from Chatham Lodging Trust
- Industry-leading margins and RevPAR, strong balance sheet, and upside from tech market recovery.CLDT
Investor presentation2 Mar 2026 - Industry-leading margins, reduced leverage, and a return to profitability set the stage for 2026.CLDT
Q4 202527 Feb 2026 - Q2 RevPAR up 4%, Phoenix hotel acquired, and balance sheet strengthened despite higher costs.CLDT
Q2 20242 Feb 2026 - Q3 RevPAR growth, asset sales, and tech market strength support debt reduction and outperformance.CLDT
Q3 202416 Jan 2026 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Board urges approval of Equity Incentive Plan amendment to sustain aligned, cost-effective pay.CLDT
Proxy Filing2 Dec 2025 - Outperforming peers in RevPAR and margins, with strong growth potential from business travel recovery.CLDT
Investor Presentation27 Nov 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025